{"id":"https://openalex.org/W1991751982","doi":"https://doi.org/10.1002/ddr.430010711","title":"Pupil size and critical flicker fusion threshold: A reevaluation","display_name":"Pupil size and critical flicker fusion threshold: A reevaluation","publication_year":1982,"publication_date":"1982-01-01","ids":{"openalex":"https://openalex.org/W1991751982","doi":"https://doi.org/10.1002/ddr.430010711","mag":"1991751982"},"language":"en","primary_location":{"id":"doi:10.1002/ddr.430010711","doi":"https://doi.org/10.1002/ddr.430010711","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.430010711","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113623363","display_name":"JAMES R. LAWRENCE","orcid":"https://orcid.org/0009-0000-2024-2881","observed_orcids":["https://orcid.org/0009-0000-2024-2881"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"J. R. Lawrence","raw_affiliation_strings":["Department of Clinical Pharmacology, Hoechst U.K. Ltd., Walton Manor, Milton Keynes, Buckinghamshire, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Hoechst U.K. Ltd., Walton Manor, Milton Keynes, Buckinghamshire, England","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076295262","display_name":"Jill I McEwen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. McEwen","raw_affiliation_strings":["Department of Clinical Pharmacology, Hoechst U.K. Ltd., Walton Manor, Milton Keynes, Buckinghamshire, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Hoechst U.K. Ltd., Walton Manor, Milton Keynes, Buckinghamshire, England","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039855118","display_name":"Peter Stonier","orcid":"https://orcid.org/0009-0009-9760-0793","observed_orcids":["https://orcid.org/0009-0009-9760-0793"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. D. Stonier","raw_affiliation_strings":["Department of Clinical Pharmacology, Hoechst U.K. Ltd., Walton Manor, Milton Keynes, Buckinghamshire, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Hoechst U.K. Ltd., Walton Manor, Milton Keynes, Buckinghamshire, England","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063262519","display_name":"A. W. Pidgen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. W. Pidgen","raw_affiliation_strings":["Department of Clinical Pharmacology, Hoechst U.K. Ltd., Walton Manor, Milton Keynes, Buckinghamshire, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Hoechst U.K. Ltd., Walton Manor, Milton Keynes, Buckinghamshire, England","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5113623363"],"corresponding_institution_ids":[],"apc_list":{"value":3980,"currency":"USD","value_usd":3980},"apc_paid":null,"fwci":0.247,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.45932646,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"2","issue":"S1","first_page":"67","last_page":"75"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10427","display_name":"Visual perception and processing mechanisms","score":0.5259000062942505,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10427","display_name":"Visual perception and processing mechanisms","score":0.5259000062942505,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","score":0.09690000116825104,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10381","display_name":"Ophthalmology and Visual Impairment Studies","score":0.044199999421834946,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/critical-flicker-fusion-threshold","display_name":"critical flicker fusion threshold","score":0.9629999995231628},{"id":"https://openalex.org/keywords/pupil-size","display_name":"pupil size","score":0.9599999785423279},{"id":"https://openalex.org/keywords/pilocarpine","display_name":"pilocarpine","score":0.8790000081062317},{"id":"https://openalex.org/keywords/homatropine","display_name":"homatropine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/clobazam","display_name":"clobazam","score":0.9589999914169312},{"id":"https://openalex.org/keywords/pupil-dilation","display_name":"pupil dilation","score":0.8949999809265137},{"id":"https://openalex.org/keywords/miosis","display_name":"miosis","score":0.9570000171661377},{"id":"https://openalex.org/keywords/artificial-pupil","display_name":"artificial pupil","score":0.8679999709129333}],"concepts":[{"id":"https://openalex.org/C152484397","wikidata":"https://www.wikidata.org/wiki/Q186129","display_name":"Flicker fusion threshold","level":3,"score":0.9091138243675232},{"id":"https://openalex.org/C2779109636","wikidata":"https://www.wikidata.org/wiki/Q1128283","display_name":"Mydriasis","level":2,"score":0.7904855012893677},{"id":"https://openalex.org/C2777394604","wikidata":"https://www.wikidata.org/wiki/Q173318","display_name":"Pupil","level":2,"score":0.7808973789215088},{"id":"https://openalex.org/C3019054092","wikidata":"https://www.wikidata.org/wiki/Q7260673","display_name":"Pupil size","level":3,"score":0.708942174911499},{"id":"https://openalex.org/C2777724181","wikidata":"https://www.wikidata.org/wiki/Q596899","display_name":"Miosis","level":2,"score":0.6560789942741394},{"id":"https://openalex.org/C2987277156","wikidata":"https://www.wikidata.org/wiki/Q173318","display_name":"Pupil diameter","level":3,"score":0.5069823265075684},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.49959635734558105},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4110196828842163},{"id":"https://openalex.org/C548259974","wikidata":"https://www.wikidata.org/wiki/Q569965","display_name":"Audiology","level":1,"score":0.3332476317882538},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2862125039100647},{"id":"https://openalex.org/C19743564","wikidata":"https://www.wikidata.org/wiki/Q25378119","display_name":"Flicker","level":2,"score":0.18247488141059875},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.13217458128929138},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C119599485","wikidata":"https://www.wikidata.org/wiki/Q43035","display_name":"Electrical engineering","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/ddr.430010711","doi":"https://doi.org/10.1002/ddr.430010711","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.430010711","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1969868793","https://openalex.org/W1984297877","https://openalex.org/W1989302378","https://openalex.org/W1994657866","https://openalex.org/W2030535937","https://openalex.org/W2051911481","https://openalex.org/W2062586964","https://openalex.org/W2132326210","https://openalex.org/W2172397736","https://openalex.org/W2607688586","https://openalex.org/W2779821312","https://openalex.org/W3167891112","https://openalex.org/W4238101309","https://openalex.org/W4240663152","https://openalex.org/W6718393827"],"related_works":["https://openalex.org/W2055832826","https://openalex.org/W2104289492","https://openalex.org/W4247267335","https://openalex.org/W1979690514","https://openalex.org/W7002003634","https://openalex.org/W2121114184","https://openalex.org/W1506262034","https://openalex.org/W2795257773","https://openalex.org/W2971954636","https://openalex.org/W2049457605"],"abstract_inverted_index":{"A":[0],"commonly":[1],"used":[2],"method":[3],"of":[4,21,50,61,82,113,145,175,179],"evaluating":[5],"critical":[6],"flicker":[7],"fusion":[8],"(CFF)":[9],"threshold\u2014the":[10],"Leeds":[11],"psychomotor":[12],"tester\u2014has":[13],"been":[14],"assessed":[15,132],"with":[16,39],"regard":[17],"to":[18,54,70,87,104,159],"the":[19,111,122,134,154,173],"influence":[20],"pupil-size":[22,185],"alteration":[23],"on":[24,64,117,187],"CFF":[25,62,94,146,188],"measurements.":[26],"Six":[27],"healthy":[28],"volunteers,":[29],"(three":[30],"males,":[31],"three":[32],"females)":[33],"took":[34],"part":[35],"and":[36,43,119,126],"were":[37,147],"treated":[38],"saline,":[40],"pilocarpine":[41,166],"2%,":[42],"homatropine":[44,163],"1%":[45],"eye":[46,167],"drops":[47],"at":[48],"intervals":[49],"one":[51,192],"week":[52],"according":[53],"a":[55,91,108,150],"balanced":[56],"crossover":[57],"design.":[58],"The":[59],"regression":[60],"threshold":[63,95],"pupil":[65,83,129,178],"size,":[66,130],"both":[67,124],"measured":[68],"up":[69],"7":[71],"hr":[72],"after":[73,137],"treatment,":[74],"was":[75,131],"highly":[76],"significant":[77,140],"in":[78,93,142,189],"all":[79,190],"subjects.":[80],"Increases":[81],"size":[84],"from":[85,102],"2":[86,103,180],"8":[88],"mm":[89,181],"produced":[90],"rise":[92],"which":[96],"varied":[97],"between":[98],"individuals":[99],"but":[100,191],"ranged":[101],"9":[105],"Hz.":[106],"In":[107],"separate":[109,151],"study,":[110],"effect":[112],"clobazam":[114],"20":[115],"mg":[116],"binocular":[118],"monocular":[120],"CFF,":[121],"latter":[123],"uncorrected":[125],"corrected":[127,183],"for":[128,184],"over":[133],"8-hr":[135],"period":[136],"treatment.":[138],"No":[139],"changes":[141],"either":[143],"measure":[144],"observed.":[148],"On":[149],"study":[152],"day":[153],"same":[155],"four":[156],"subjects":[157],"submitted":[158],"mydriasis/miosis":[160],"induced":[161],"by":[162,165],"followed":[164],"drops.":[168],"This":[169],"procedure":[170],"showed":[171],"that":[172],"use":[174],"an":[176],"artificial":[177],"adequately":[182],"influences":[186],"subject.":[193]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}